Thromboxane A2-
**Core Concept**
Thromboxane A2 (TXA2) is a prostanoid synthesized from arachidonic acid through the cyclooxygenase pathway. It plays a crucial role in platelet aggregation, vasoconstriction, and thrombosis. TXA2 is produced by platelets and is involved in the formation of blood clots.
**Why the Correct Answer is Right**
TXA2 exerts its effects by binding to the thromboxane A2 receptor (TP receptor) on platelets, leading to an increase in intracellular calcium levels and activation of phospholipase C. This results in platelet aggregation and vasoconstriction. TXA2 also inhibits the production of prostacyclin, a vasodilator, which further contributes to its prothrombotic effects.
**Why Each Wrong Option is Incorrect**
**Option A:** TXA2 is not a vasodilator; it is a vasoconstrictor.
**Option B:** TXA2 does not inhibit platelet aggregation; it promotes platelet aggregation.
**Option C:** TXA2 is not produced by endothelial cells; it is produced by platelets.
**Clinical Pearl / High-Yield Fact**
TXA2 is often referred to as the "platelet aggregator" due to its potent effects on platelet activation and aggregation. Aspirin, a nonsteroidal anti-inflammatory drug (NSAID), inhibits the production of TXA2 by blocking the cyclooxygenase enzyme, which is why it is often used to prevent thrombotic events.
**Correct Answer:** D.